NetworkNewsBreaks

TuesdayJul 18, 2023 2:54 pm

NetworkNewsBreaks – Bollinger Motors, a Majority-Owned EV Truck Company of Mullen Automotive Inc. (NASDAQ: MULN), Kicks off ‘Design Validation’ Pilot Builds

Bollinger Motors, which in September of 2022 became a majority-owned EV truck company of Mullen Automotive (NASDAQ: MULN), today announced the start of its “design validation” pilot builds of the B4 all-electric Class 4 chassis cabs for testing and demonstration. According to the announcement, manufacturing of the pilot vehicles has kicked off in partnership with Roush Industries Inc. at its facility in Livonia, Michigan. The first five completed chassis cabs are expected to roll out this summer, with another 15+ vehicles by the end of the third quarter of 2023. “Bollinger Motors has over eight years of experience in developing,…

Continue Reading

TuesdayJul 18, 2023 2:00 pm

NetworkNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Completes Game-Changing Integration with Samsara

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company on a mission to revolutionize cross-border shipping by offering carriers increased growth opportunities and shippers with flexibility, visibility and simplicity, recently announced its new integration with Samsara, a pioneer of the Connected Operations(TM) Cloud. “Samsara’s Connected Operations Cloud has helped differentiate the company in its segment by making it easy for organizations to access, analyze and act upon real-time data from tracks, trailers, warehouses, and equipment. In turn, users have enjoyed improved safety, efficiency, and sustainability, allowing for better and even more profitable operations. With the integration, Fr8App customers can now view…

Continue Reading

TuesdayJul 18, 2023 1:38 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Enters Exclusive License Agreement with University of Pittsburgh

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has signed an exclusive license agreement with the University of Pittsburgh. The agreement grants Genprex worldwide, exclusive rights to a patent application and related technology for a gene therapy targeting both type 1 and type 2 diabetes. The therapy utilizes Pdx1 (“Pdx1”) and MafA (“MafA”) genes controlled by an MafB (“MafB”) promoter and administered through an adeno-associated virus (“AAV”) vector directly into the pancreatic duct. Preclinical data from nonhuman primate models of type 1 diabetes show promising results, with significant decreases…

Continue Reading

TuesdayJul 18, 2023 1:20 pm

NetworkNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Presenting 6 Posters on Its Lead Therapeutic Candidate at AAIC 2023

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, today announced that it is presenting six in-person posters highlighting data from its phase 1 clinical trials investigating the company’s lead therapeutic candidate, IGC-AD1, at the Alzheimer’s Association International Conference (“AAIC”). The event is taking place July 16-20, 2023, in Amsterdam, Netherlands. “We are honored to have six posters accepted for presentation at AAIC 2023, a prestigious meeting of leading Alzheimer’s disease experts and pharmaceutical innovators,” said Ram Mukunda, CEO of IGC. “The data being presented at AAIC from our phase 1 clinical trial of IGC-AD1 demonstrates the positive impact of…

Continue Reading

TuesdayJul 18, 2023 1:03 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports Arbitration Panel Finding in Syneos Health (NASDAQ: SYNH) Proceeding

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, is reporting that an arbitration panel has found that Syneos Health (NASDAQ: SYNH) failed to use commercially reasonable efforts in conducting its trial for FSD 201. According to the announcement, Syneos Health filed an arbitration proceeding against FSD Pharma in 2022. Syneos claimed that FSD Pharma owed Syneos Health $3,915,388.69 in damages as well as interest on that amount in relation to a failed phase 2 FDA trial…

Continue Reading

TuesdayJul 18, 2023 12:01 pm

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to Host Annual Meeting via Live Webcast

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced that it will hold its 2023 annual meeting of stockholders (the “annual meeting”) at 1 p.m. Pacific Time on Thursday, July 20. The announcement reads, “We cordially invite everyone to attend the annual meeting, which will be held entirely online live via webcast. Visit www.meetnow.global/MMK2GSH to join the meeting live on Thursday, submit questions, and vote*. Supported browsers include Chrome, MS Edge, Firefox and Safari.” *Voting and asking questions at the meeting requires entry via a valid control number, which is…

Continue Reading

MondayJul 17, 2023 2:37 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Ready to Support Governmental Prioritization of Near-Term Quantum Development

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, is helping fuel the adoption of near-term quantum computing solutions against a backdrop of increased government assessment, investment and legislation. “As more governments start to consider quantum applications and the use of quantum technologies to solve public sector challenges, D-Wave offers solutions oriented towards addressing optimization problems commonly faced by government agencies… Public sector solutions for emergency response, sustainability, supply chain, infrastructure, telecommunications and energy can all benefit from D-Wave’s quantum technology,” a recent article reads. “The United States National Quantum Initiative is up for reauthorization by September…

Continue Reading

MondayJul 17, 2023 2:16 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Positioned to Expand Its Clinical Pipeline

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently announced that its research collaborators presented positive preclinical data for the reexpression of the NPRL2 gene. “The collaborators conducted the studies using the ONCOPREX(R) Nanoparticle Delivery System to deliver the NPRL2 gene to KRAS/STK11 mutant, anti-PD1 resistant, human NSCLC metastases in humanized mouse models, presenting the data at the 2023 American Association of Cancer Research (‘AACR’) annual meeting, held in April,” reads a recent article. “According to Genprex President, Chairman and CEO Rodney Varner, the use of ONCOPREX(R) to deliver…

Continue Reading

MondayJul 17, 2023 1:13 pm

NetworkNewsBreaks – Institute of Biomedical Research Corp. (MRES) Unveils Meticulously Crafted Line of Teas Sourced from Kenya

Institute of Biomedical Research (OTC: MRES) (doing business as M2Bio Sciences) is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence and evidence-based sustainable products and solutions. M2Bio Sciences today announced the forthcoming launch of a captivating line of teas sourced from the scenic gardens of Kenya. The meticulously crafted collection provides not only an exquisite sensory experience but also delivers exceptional medicinal health benefits. “We are delighted to introduce our exceptional line of purple, white and green teas from Kenya,” said Jeff Robinson, CEO of M2Bio Sciences. “Our…

Continue Reading

FridayJul 14, 2023 3:11 pm

NetworkNewsBreaks – GolfLync Inc. Remembers the Earliest Rule of the Game with Social App

GolfLync is the company behind the GolfLync app – a social network for matching golf games and players. “In case you’re not a golfer, GolfLync is the new thing golfers use to ensure that they always play with people they actually enjoy (go to www.GolfLync.com or see the Apple App Store for 5-star reviews),” reads a recent article. The piece discusses the unexpected agreement between PGA Tour commissioner Jay Monahan and Saudi businessman Yasir bin Othman Al-Rumayyan, governor of the Saudi Public Investment Fund (“PIF”), that the PGA and LIV Golf would suddenly merge. “Not surprisingly, some key players who…

Continue Reading